Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for traumatic brain injury with intracerebral hemorrhage
IRCT20190422043339N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) and intracerebral hemorrhage (ICH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Brain contusion and intracerebral hemorrhage. Started Sep 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20190422043339N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190422043339N1.